The Flavonoid Hesperidin Methyl Chalcone Targets Cytokines and Oxidative Stress to Reduce Diclofenac-Induced Acute Renal Injury: Contribution of the Nrf2 Redox-Sensitive Pathway

• Published in: Antioxidants Vol. 11; no. 7; p. 1261
• Main Authors: Bussmann, Allan J. C., Zaninelli, Tiago H., Saraiva-Santos, Telma, Fattori, Victor, Guazelli, Carla F. S., Bertozzi, Mariana M., Andrade, Ketlem C., Ferraz, Camila R., Camilios-Neto, Doumit, Casella, Antônio M. B., Casagrande, Rubia, Borghi, Sergio M., Verri, Waldiceu A.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 27.06.2022; MDPI
• Subjects: Acids; acute renal injury; Analgesics; Antioxidants; Arthritis; citrus flavonoid; Creatinine; Cytokines; Diclofenac; Enzymes; Experiments; Flavonoids; Gene expression; Hesperidin; hesperidin methylchalcone; Inflammation; Interleukin 10; Interleukin 6; Kidneys; Lipid peroxidation; Lipids; Nonsteroidal anti-inflammatory drugs; Nrf2; Oxidants; Oxidative stress; Pain; Urine; γ-Interferon; Brazil
• DOI: 10.3390/antiox11071261
• ISSN: 2076-3921

Hesperidin is derived from citrus fruits among other plants. Hesperidin was methylated to increase its solubility, generating hesperidin methyl chalcone (HMC), an emerging flavonoid that possess anti-inflammatory and antioxidant properties. The nuclear factor erythroid 2-related factor 2 (Nrf2) is a powerful regulator of cellular resistance to oxidant products. Previous data evidenced HMC can activate Nrf2 signaling, providing antioxidant protection against diverse pathological conditions. However, its effects on kidney damage caused by non-steroidal anti-inflammatory drugs (NSAIDs) have not been evaluated so far. Mice received a nephrotoxic dose of diclofenac (200 mg/kg) orally followed by intra-peritoneal (i.p.) administration of HMC (0.03–3 mg/kg) or vehicle. Plasmatic levels of urea, creatinine, oxidative stress, and cytokines were assessed. Regarding the kidneys, oxidative parameters, cytokine production, kidney swelling, urine NGAL, histopathology, and Nrf2 mRNA expression and downstream targets were evaluated. HMC dose-dependently targeted diclofenac systemic alterations by decreasing urea and creatinine levels, and lipid peroxidation, as well as IL-6, IFN-γ, and IL-33 production, and restored antioxidant properties in plasma samples. In kidney samples, HMC re-established antioxidant defenses, inhibited lipid peroxidation and pro-inflammatory cytokines and upregulated IL-10, reduced kidney swelling, urine NGAL, and histopathological alterations. Additionally, HMC induced mRNA expression of Nrf2 and its downstream effectors HO-1 and Nqo1, as well as reduced the levels of Keap1 protein detected in renal tissue. The present data demonstrate HMC is a potential compound for the treatment of acute renal damage caused by diclofenac, a routinely prescribed non-steroidal anti-inflammatory drug.